Search

Author/Creator Wetherill, Laura F.

1. Oncolytic virus treatment differentially affects the CD56dim and CD56bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity. Issue 1 (9th March 2022)

Authors:
Wantoch, Michelle; Wilson, Erica B.; Droop, Alastair P.; Phillips, Sarah L.; Coffey, Matt; El‐Sherbiny, Yasser M.; Holmes, Tim D.; Melcher, Alan A.; Wetherill, Laura F.; Cook, Graham P.
Journal:
Immunology
Issue:
Volume 166:Issue 1(2022)
Page Start:
104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Structure‐guided design affirms inhibitors of hepatitis C virus p7 as a viable class of antivirals targeting virion release. Issue 2 (24th December 2013)

Authors:
Foster, Toshana L.; Thompson, Gary S.; Kalverda, Arnout P.; Kankanala, Jayakanth; Bentham, Matthew; Wetherill, Laura F.; Thompson, Joseph; Barker, Amy M.; Clarke, Dean; Noerenberg, Marko; Pearson, Arwen R.; Rowlands, David J.; Homans, Steven W.; Harris, Mark; Foster, Richard; Griffin, Stephen
Journal:
Hepatology
Issue:
Volume 59:Issue 2(2014:Feb.)
Page Start:
408
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search